Finance

Lists
Outlook: 53.8% bullish·0.0% bearish
Go to analysis
BDX:NYSE
Becton Dickinson and Co
$182.68
-0.04%
(-0.070) 1D
Oct 9, 11:15:23 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BDX...
Open
$181.89
High
$183.77
Low
$181.51
Mkt. cap
49.78B
Avg. vol.
1.79M
Volume
157.47K
Dividend
2.30%
Quarterly dividend
$1.05
Ex-dividend date
Sep 9, 2026
P/E ratio
55.20
52-wk high
$193.07
52-wk low
$127.54
EPS
$3.31
Beta
0.21
Shares outstanding
272.39M
No. of employees
72K
Open
$181.89
High
$183.77
Low
$181.51
Mkt. cap
49.78B
Avg. vol.
1.79M
Volume
157.47K
Dividend
2.30%
Quarterly dividend
$1.05
Ex-dividend date
Sep 9, 2026
P/E ratio
55.20
52-wk high
$193.07
52-wk low
$127.54
EPS
$3.31
Beta
0.21
Shares outstanding
272.39M
No. of employees
72K
News stories
From web sources and news partners
Profile
Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas. BD is ranked #211 in the 2024 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2023. Wikipedia
About Becton Dickinson and Co
CEOThomas Polen
Employees72K
Founded1897
HeadquartersFranklin Lakes, New Jersey, United States
SectorMedical device
Websitebd.com
Analyst ratings
Based on 10 analysts giving stock ratings to BDX in the past 3 months
Buy
Buy
4
Hold
5
Sell
1
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for BDX in the last 3 months.
Highest
Current $182.68
$210.00 (+14.96%)
Average
$191.80 (+4.99%)
Lowest
$165.00 (-9.68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Travis Steed
Bank of America Securities
Hold
Maintained
$200.00
+9.5%
10/06/2026
Christopher Pasquale
Barclays
Sell
Initiated
$165.00
-9.7%
10/07/2026
Matt Miksic
Barclays
Sell
Maintained
$165.00
-9.7%
10/07/2026
Joanne Wuensch
Citi
Buy
Maintained
$208.00
+13.9%
10/05/2026
Kendall Au
RBC Capital
Hold
Maintained
$190.00
+4%
10/01/2026
Matthew Taylor
Jefferies
Buy
Maintained
$210.00
+15%
09/08/2026
Josh Jennings
TD Cowen
Hold
Reiterated
$182.00
-0.4%
08/17/2026
Patrick Wood
UBS
Buy
Reiterated
$205.00
+12.2%
08/12/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
$188.00
+2.9%
08/10/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
$195.00
+6.7%
08/11/2026
Jason Bednar
Piper Sandler
Hold
Reiterated
$175.00
-4.2%
08/07/2026
Shagun Singh Chadha
RBC Capital
Hold
Maintained
$180.00
-1.5%
08/06/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
$180.00
-1.5%
07/06/2026
David Roman
Goldman Sachs
Hold
Initiated
$167.00
-8.6%
04/10/2026
David Toung
Argus Research
Buy
Reiterated
$180.00
-1.5%
03/20/2026
Unknown Analyst
Jefferies
Buy
Maintained
$190.00
+4%
02/10/2026
Unknown Analyst
J.P. Morgan
Hold
Maintained
$175.00
-4.2%
02/10/2026
Larry Biegelsen
Wells Fargo
Hold
Maintained
$157.00
-14.1%
02/10/2026
Last report
Aug 6, 2026
Fiscal period
Q3 2026
$3.23 / $3.14
+2.93%beat
Revenue / Est. (USD)
4.98B / 4.89B
+1.91%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.89B
4.49B
4.71B
4.98B
Cost of goods sold
3.09B
2.43B
2.56B
2.67B
Cost of revenue
3.09B
2.43B
2.56B
2.67B
Research and development expenses
322.00M
235.00M
249.00M
258.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.43B
1.23B
1.24B
1.27B
Operating expense
1.75B
1.46B
1.46B
1.53B
Total operating expenses
4.84B
3.90B
4.02B
4.20B
Operating income
1.05B
590.00M
695.00M
784.00M
Other non operating income
92.00M
-12.00M
109.00M
30.00M
EBT including unusual items
510.00M
311.00M
39.00M
553.00M
EBT excluding unusual items
947.00M
429.00M
664.00M
686.00M
Income tax expense
17.00M
-
76.00M
102.00M
Effective tax rate
3.33%
-
194.87%
18.44%
Other operating expenses
-4.00M
1.00M
-26.00M
-
Net income
493.00M
383.00M
-311.00M
377.00M
Net profit margin
8.37%
8.54%
-6.60%
7.57%
Earnings per share
3.96
2.91
2.90
3.23
Interest and investment income
5.00M
4.00M
9.00M
4.00M
Interest expense
-155.00M
-153.00M
-149.00M
-132.00M
Net interest expenses
-150.00M
-149.00M
-140.00M
-128.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.68B
1.20B
1.22B
1.35B
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps